Clinical Trials

Obesity in patients who have had a heart attack or stroke

Posted on 12/30/2018
Research has shown that treatment with semaglutide (an FDA approved drug) may reduce the risk of stroke and heart attack in people with type 2 diabetes.  The purpose of this study is to assess whether semaglutide reduces the risk of heart attack and stroke in people who are overweight or obese.

You may qualify to participate in this study if:
  • You have had a stroke or heart attack, or have poor circulation (peripheral arterial disease)
  • You are 45 years of age or older
  • You are overweight or obese
  • You are able to attend regular clinic visits and receive phone calls over a period of 3-5 years

If you qualify for this study, you will receive study-related care, including regular health check-ups and guidance on healthy lifestyle choices at no cost to you or your insurnce. 

You will also be compensated $50 for every clinic visit you attend up to $1,250.  

Call our office for more information - (903) 238-8854
What Our Research Patients are Saying
Everyone at DCOL Research is friendly and helpful. They all have a great sense of humor, which really helps you relax.  I have participated in several studies with them and the research coordinator I see is awesome. She makes you feel that your health is her top priority.  The research doctor is really good too and if you start having problems during the study he will take care of you. This research clinic is like a family, and once you participate in a study, you are just part of the family.     R. O.

Contact Form


  
DCOL of Longview